The reasons for these observations could be attributed as follows; Firstly, patients who received NAC were more likely to have advanced stage breast cancer and to have hormone receptor negative and/or HER2 positive tumors with a high biological grade. The gene discussed is ERBB2; the disease is breast cancer.